Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matthew Biegler is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/19/2025 | OLMA | Buy Now | Olema Pharmaceuticals | $3.92 | 537.76% | Matthew Biegler37% | $30 → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 02/12/2025 | ARVN | Buy Now | Arvinas | $8.70 | 417.24% | Matthew Biegler37% | $40 → $45 | Maintains | Outperform | Get Alert |
| 12/10/2024 | GILD | Buy Now | Gilead Sciences | $107.00 | 7.48% | Matthew Biegler37% | $105 → $115 | Reiterates | Outperform → Outperform | Get Alert |
| 10/31/2024 | ARVN | Buy Now | Arvinas | $8.70 | 359.77% | Matthew Biegler37% | $50 → $40 | Maintains | Outperform | Get Alert |
| 10/29/2024 | IDYA | Buy Now | IDEAYA Biosciences | $18.21 | 191.05% | Matthew Biegler37% | $53 → $53 | Reiterates | Outperform → Outperform | Get Alert |
| 09/19/2024 | TYRA | Buy Now | Tyra Biosciences | $11.16 | 195.7% | Matthew Biegler37% | $25 → $33 | Maintains | Outperform | Get Alert |
| 09/16/2024 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 1017.32% | Matthew Biegler37% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 09/10/2024 | RLAY | Buy Now | Relay Therapeutics | $3.35 | — | Matthew Biegler37% | — | Downgrade | Outperform → Perform | Get Alert |
| 08/13/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.47 | 100.8% | Matthew Biegler37% | $17 → $15 | Maintains | Outperform | Get Alert |
| 08/08/2024 | ALLO | Buy Now | Allogene Therapeutics | $1.71 | 543.27% | Matthew Biegler37% | $13 → $11 | Assumes | → Outperform | Get Alert |
| 08/08/2024 | TYRA | Buy Now | Tyra Biosciences | $11.16 | 124.01% | Matthew Biegler37% | $28 → $25 | Maintains | Outperform | Get Alert |
| 08/07/2024 | OLMA | Buy Now | Olema Pharmaceuticals | $3.92 | 665.31% | Matthew Biegler37% | $30 → $30 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2024 | RLAY | Buy Now | Relay Therapeutics | $3.35 | 616.42% | Matthew Biegler37% | $25 → $24 | Maintains | Outperform | Get Alert |
| 08/07/2024 | IDYA | Buy Now | IDEAYA Biosciences | $18.21 | 191.05% | Matthew Biegler37% | $60 → $53 | Maintains | Outperform | Get Alert |
| 07/31/2024 | ARVN | Buy Now | Arvinas | $8.70 | 474.71% | Matthew Biegler37% | $70 → $50 | Maintains | Outperform | Get Alert |
| 07/10/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.47 | 127.58% | Matthew Biegler37% | $17 → $17 | Maintains | Outperform | Get Alert |
| 07/08/2024 | IDYA | Buy Now | IDEAYA Biosciences | $18.21 | 229.49% | Matthew Biegler37% | $53 → $60 | Maintains | Outperform | Get Alert |
| 07/08/2024 | BPMC | Buy Now | Blueprint Medicines | $90.48 | 38.15% | Matthew Biegler37% | $114 → $125 | Maintains | Outperform | Get Alert |
| 07/03/2024 | TYRA | Buy Now | Tyra Biosciences | $11.16 | 150.9% | Matthew Biegler37% | $28 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 07/02/2024 | RNAC | Buy Now | Cartesian Therapeutics | $14.60 | — | Matthew Biegler37% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 06/24/2024 | RNAC | Buy Now | Cartesian Therapeutics | $14.60 | 242.47% | Matthew Biegler37% | $50 → $50 | Reiterates | Outperform → Outperform | Get Alert |
| 06/18/2024 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 1296.65% | Matthew Biegler37% | $50 → $25 | Maintains | Outperform | Get Alert |
| 06/14/2024 | RNAC | Buy Now | Cartesian Therapeutics | $14.60 | 242.47% | Matthew Biegler37% | $50 → $50 | Maintains | Outperform | Get Alert |
| 06/04/2024 | RNAC | Buy Now | Cartesian Therapeutics | $14.60 | 242.47% | Matthew Biegler37% | → $50 | Initiates | → Outperform | Get Alert |
| 05/14/2024 | FULC | Buy Now | Fulcrum Therapeutics | $2.97 | 371.38% | Matthew Biegler37% | $16 → $14 | Maintains | Outperform | Get Alert |
| 05/13/2024 | VOR | Buy Now | Vor Biopharma | $0.87 | 1052.34% | Matthew Biegler37% | $15 → $10 | Reiterates | Outperform → Outperform | Get Alert |
| 05/13/2024 | TYRA | Buy Now | Tyra Biosciences | $11.16 | 150.9% | Matthew Biegler37% | $25 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 05/06/2024 | RLAY | Buy Now | Relay Therapeutics | $3.35 | 646.27% | Matthew Biegler37% | $33 → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 04/01/2024 | ELTX | Buy Now | Elicio Therapeutics | $8.70 | — | Matthew Biegler37% | — | Reiterates | Perform → Perform | Get Alert |
| 03/21/2024 | VOR | Buy Now | Vor Biopharma | $0.87 | 1628.51% | Matthew Biegler37% | $17 → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 03/19/2024 | ALPN | Buy Now | Alpine Immune Sciences | — | — | Matthew Biegler37% | $33 → $44 | Reiterates | Outperform → Outperform | Get Alert |
| 03/12/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.47 | 127.58% | Matthew Biegler37% | $14 → $17 | Maintains | Outperform | Get Alert |
| 03/12/2024 | OLMA | Buy Now | Olema Pharmaceuticals | $3.92 | 435.71% | Matthew Biegler37% | $21 → $21 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2024 | ARVN | Buy Now | Arvinas | $8.70 | 819.54% | Matthew Biegler37% | $95 → $80 | Reiterates | Outperform → Outperform | Get Alert |
| 02/27/2024 | FATE | Buy Now | Fate Therapeutics | $0.97 | — | Matthew Biegler37% | — | Reiterates | Perform → Perform | Get Alert |
| 02/27/2024 | DAWN | Buy Now | Day One Biopharmaceutical | $8.28 | — | Matthew Biegler37% | — | Reiterates | Perform → Perform | Get Alert |
| 10/27/2023 | BPMC | Buy Now | Blueprint Medicines | $90.48 | -6.06% | Matthew Biegler37% | → $85 | Upgrade | Perform → Outperform | Get Alert |
| 09/06/2023 | OLMA | Buy Now | Olema Pharmaceuticals | $3.92 | 435.71% | Matthew Biegler37% | → $21 | Reiterates | Outperform → Outperform | Get Alert |
| 08/22/2023 | FULC | Buy Now | Fulcrum Therapeutics | $2.97 | 438.72% | Matthew Biegler37% | → $16 | Reiterates | Outperform → Outperform | Get Alert |
| 08/14/2023 | MDNA | Buy Now | Medicenna Therapeutics | — | — | Matthew Biegler37% | $8 → $3 | Maintains | Outperform | Get Alert |
| 08/11/2023 | APTO | Buy Now | Aptose Biosciences | $3.78 | 296.83% | Matthew Biegler37% | $1500 → $450 | Maintains | Outperform | Get Alert |
| 08/11/2023 | IDYA | Buy Now | IDEAYA Biosciences | $18.21 | 92.2% | Matthew Biegler37% | $30 → $35 | Maintains | Outperform | Get Alert |
| 08/09/2023 | RLAY | Buy Now | Relay Therapeutics | $3.35 | 885.07% | Matthew Biegler37% | → $33 | Reiterates | Outperform → Outperform | Get Alert |
| 07/21/2023 | OLMA | Buy Now | Olema Pharmaceuticals | $3.92 | 435.71% | Matthew Biegler37% | → $21 | Initiates | → Outperform | Get Alert |
| 06/12/2023 | APTO | Buy Now | Aptose Biosciences | $3.78 | 1222.75% | Matthew Biegler37% | $270 → $1500 | Maintains | Outperform | Get Alert |
| 06/02/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | Matthew Biegler37% | → $30 | Initiates | → Outperform | Get Alert |
| 06/02/2023 | ACRV | Buy Now | Acrivon Therapeutics | $5.46 | 357.88% | Matthew Biegler37% | → $25 | Initiates | → Outperform | Get Alert |
| 05/26/2023 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 2693.3% | Matthew Biegler37% | → $50 | Reiterates | Outperform → Outperform | Get Alert |
| 05/16/2023 | FULC | Buy Now | Fulcrum Therapeutics | $2.97 | 438.72% | Matthew Biegler37% | $20 → $16 | Maintains | Outperform | Get Alert |
| 05/15/2023 | VOR | Buy Now | Vor Biopharma | $0.87 | 1974.21% | Matthew Biegler37% | → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 05/11/2023 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 2693.3% | Matthew Biegler37% | → $50 | Reiterates | Outperform → Outperform | Get Alert |
| 05/09/2023 | APTO | Buy Now | Aptose Biosciences | $3.78 | 138.1% | Matthew Biegler37% | → $4050 | Reiterates | → Outperform | Get Alert |
| 05/08/2023 | TYRA | Buy Now | Tyra Biosciences | $11.16 | 124.01% | Matthew Biegler37% | → $25 | Reiterates | → Outperform | Get Alert |
| 04/18/2023 | RLAY | Buy Now | Relay Therapeutics | $3.35 | 885.07% | Matthew Biegler37% | → $33 | Maintains | Outperform | Get Alert |
| 03/24/2023 | VOR | Buy Now | Vor Biopharma | $0.87 | 1974.21% | Matthew Biegler37% | → $18 | Reiterates | → Outperform | Get Alert |
| 03/16/2023 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.47 | 87.42% | Matthew Biegler37% | → $14 | Upgrade | Perform → Outperform | Get Alert |
| 02/27/2023 | FULC | Buy Now | Fulcrum Therapeutics | $2.97 | 573.4% | Matthew Biegler37% | $26 → $20 | Maintains | Outperform | Get Alert |
| 02/03/2023 | DAWN | Buy Now | Day One Biopharmaceutical | $8.28 | — | Matthew Biegler37% | — | Initiates | → Perform | Get Alert |
| 02/03/2023 | TYRA | Buy Now | Tyra Biosciences | $11.16 | 52.33% | Matthew Biegler37% | → $17 | Initiates | → Outperform | Get Alert |
| 02/03/2023 | RLAY | Buy Now | Relay Therapeutics | $3.35 | 885.07% | Matthew Biegler37% | → $33 | Initiates | → Outperform | Get Alert |
| 12/22/2022 | NKTX | Buy Now | Nkarta | $1.52 | — | Matthew Biegler37% | — | Downgrade | Outperform → Perform | Get Alert |
| 12/22/2022 | FATE | Buy Now | Fate Therapeutics | $0.97 | — | Matthew Biegler37% | — | Downgrade | Outperform → Perform | Get Alert |
| 12/22/2022 | CELU | Buy Now | Celularity | $1.54 | — | Matthew Biegler37% | — | Downgrade | Outperform → Perform | Get Alert |
| 11/30/2022 | PRTG | Buy Now | Portage Biotech | $4.00 | 350% | Matthew Biegler37% | $520 → $360 | Maintains | Outperform | Get Alert |
| 11/14/2022 | VOR | Buy Now | Vor Biopharma | $0.87 | 1974.21% | Matthew Biegler37% | $27 → $18 | Maintains | Outperform | Get Alert |
| 11/10/2022 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 2693.3% | Matthew Biegler37% | $80 → $50 | Maintains | Outperform | Get Alert |
| 11/10/2022 | NKTX | Buy Now | Nkarta | $1.52 | 2268.42% | Matthew Biegler37% | $50 → $36 | Maintains | Outperform | Get Alert |
| 11/02/2022 | BPMC | Buy Now | Blueprint Medicines | $90.48 | — | Matthew Biegler37% | — | Downgrade | Outperform → Perform | Get Alert |
| 09/06/2022 | BPMC | Buy Now | Blueprint Medicines | $90.48 | -0.53% | Matthew Biegler37% | $80 → $90 | Maintains | Outperform | Get Alert |
| 08/16/2022 | IDYA | Buy Now | IDEAYA Biosciences | $18.21 | 9.83% | Matthew Biegler37% | $25 → $20 | Maintains | Outperform | Get Alert |
| 07/08/2022 | BPMC | Buy Now | Blueprint Medicines | $90.48 | -11.58% | Matthew Biegler37% | → $80 | Initiates | → Outperform | Get Alert |
| 06/23/2022 | MDNA | Buy Now | Medicenna Therapeutics | — | — | Matthew Biegler37% | $12 → $10 | Maintains | Outperform | Get Alert |
| 04/12/2022 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 4648.6% | Matthew Biegler37% | $100 → $85 | Maintains | Outperform | Get Alert |
| 03/08/2022 | FULC | Buy Now | Fulcrum Therapeutics | $2.97 | 1011.11% | Matthew Biegler37% | → $33 | Initiates | → Outperform | Get Alert |
| 02/22/2022 | FIXX | Buy Now | Homology Medicines | — | — | Matthew Biegler37% | — | Downgrade | Outperform → Perform | Get Alert |
| 01/28/2022 | CELU | Buy Now | Celularity | $1.54 | 484.42% | Matthew Biegler37% | → $90 | Initiates | → Outperform | Get Alert |
| 01/21/2022 | TPTX | Buy Now | Turning Point | — | — | Matthew Biegler37% | $115 → $105 | Maintains | Outperform | Get Alert |
| 12/02/2021 | VOR | Buy Now | Vor Biopharma | $0.87 | 3357.02% | Matthew Biegler37% | → $30 | Initiates | → Outperform | Get Alert |
| 11/10/2021 | TPTX | Buy Now | Turning Point | — | — | Matthew Biegler37% | $150 → $115 | Maintains | Outperform | Get Alert |
| 09/29/2021 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 4927.93% | Matthew Biegler37% | → $90 | Initiates | → Outperform | Get Alert |
| 07/16/2021 | NKTX | Buy Now | Nkarta | $1.52 | 4834.21% | Matthew Biegler37% | → $75 | Initiates | → Outperform | Get Alert |
| 03/24/2021 | APTO | Buy Now | Aptose Biosciences | $3.78 | 138.1% | Matthew Biegler37% | $3600 → $4050 | Maintains | Outperform | Get Alert |
| 12/18/2020 | MDNA | Buy Now | Medicenna Therapeutics | — | — | Matthew Biegler37% | → $12 | Initiates | → Outperform | Get Alert |
| 12/17/2020 | MDNA | Buy Now | Medicenna Therapeutics | — | — | Matthew Biegler37% | → $12 | Initiates | → Outperform | Get Alert |
| 07/10/2020 | TPTX | Buy Now | Turning Point | — | — | Matthew Biegler37% | → $90 | Initiates | → Outperform | Get Alert |
| 04/06/2020 | FATE | Buy Now | Fate Therapeutics | $0.97 | 3421.86% | Matthew Biegler37% | $36 → $34 | Maintains | Outperform | Get Alert |
| 03/16/2020 | FIXX | Buy Now | Homology Medicines | — | — | Matthew Biegler37% | → $576 | Upgrade | Perform → Outperform | Get Alert |
| 03/03/2020 | FATE | Buy Now | Fate Therapeutics | $0.97 | 3629.02% | Matthew Biegler37% | $27 → $36 | Maintains | Outperform | Get Alert |
| 11/01/2019 | FIXX | Buy Now | Homology Medicines | — | — | Matthew Biegler37% | — | Initiates | → Perform | Get Alert |
| 07/12/2019 | FATE | Buy Now | Fate Therapeutics | $0.97 | 2696.77% | Matthew Biegler37% | → $27 | Initiates | → Outperform | Get Alert |
| 01/25/2019 | APTO | Buy Now | Aptose Biosciences | $3.78 | 58.73% | Matthew Biegler37% | → $2700 | Initiates | → Outperform | Get Alert |
